And that you are willing to bet on just because so far Missling pulled out a bunch great looking p-values?
At least you didn’t dispute that we have no idea of the absolute reduction in brain volume loss and if it has any clinical relevance or measurable effect - and why would it if ADL is not a good measure in mild AD?
Have we seen data that correlates CDR-SB to reduction in brain volume loss - no not so far, but then again we have only waited a year and a half since the messed up TLR…
Market Data 
Markets 
AI
